Stryker Corp STRYKER ORD SHS
Stryker Corp STRYKER ORD SHS/ US8636671013 /
0R2S
|
24/05/2024 15:30:02
|
Diferencia
-
|
Volumen |
Bid6:00:04 |
Ask6:00:04 |
Capitalización de mecado |
Dividendo A. |
P/E Ratio |
|
330.69USD
|
-
|
360
Volumen de negocios: 6,283.11 |
-Volumen de oferta: - |
-Tamaño/ Volumen/ Formato de Ask: - |
135.51 mil millonesUSD |
0.86% |
42.64 |
Descripción de negocio
Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Consejo de gestión & Consejo de supervisión
| CEO |
| Kevin A. Lobo |
| Consejo de gestión |
| Glenn Boehnlein, Yin Becker, Katy Fink, Rob Fletcher, Viju Menon, Andy Pierce, Spencer Stiles |
| Consejo de supervisión |
| Kevin A. Lobo, Allan C. Golston, Andrew K. Silvernail, Dr. Srikant M. Datar, Giovanni Caforio, Lisa M. Skeete Tatum, Mary K. Brainerd, Rajeev Suri, Ronda E. Stryker, Sherilyn S. McCoy |
Datos de la empresa
| Nombre: |
Stryker Corporation |
| Dirección: |
2825 Airview Boulevard,Kalamazoo, Michigan 49002, USA |
| Teléfono: |
+1-269-385-2600 |
| Fax: |
+1-269-385-1062 |
| E-mail: |
-
|
| Internet: |
www.stryker.com |
| Industria: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Subsector: |
Pharmaceuticals |
| Fin del año financiero: |
31/12 |
| Acciones de libre circulación: |
64.10% |
| Fecha de OPI: |
01/01/1979 |
Calendario de la empresa
|
CW 44 | 31/10/2024
Dividend Payment
|
